title: Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology.
abstract: The 2015 Gastrointestinal Cancers Symposium (San Francisco, CA, USA; January 15-17) is the world-class conference co-sponsored by the American Society of Clinical Oncology, the American Society for Radiation Oncology, the American Gastroenterological Association Institute, and the Society of Surgical Oncology, in which the most innovative research results in digestive tract oncology are presented and discussed. In its twelfth edition, the meeting has provided new insights focusing on the underpinning biology and clinical management of gastrointestinal malignancies. More than 3,400 health care professionals gathered from all over the world to share their experiences on how to bridge the recent novelties in cancer biology with everyday medical practice. In this article, the authors report on the most significant advances, didactically moving on three different anatomic tracks: gastroesophageal malignancies, pancreatic and biliary cancers, and colorectal adenocarcinomas.
authors.affiliation: Department of Oncology, University and General Hospital, Udine, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Aprile
authors.affiliation: Medical Oncology Department, University of Turin, Candiolo, Turin, Italy ; Institute for Cancer Research and Treatment, Candiolo, Turin, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Leone
authors.affiliation: Medical Oncology Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Universita Politecnica delle Marche, Ancona, Italy.
authors.forename: Riccardo
authors.initials: R
authors.lastname: Giampieri
authors.affiliation: Department of Oncology, University and General Hospital, Udine, Italy.
authors.forename: Mariaelena
authors.initials: M
authors.lastname: Casagrande
authors.affiliation: Medical Oncology Department, University of Turin, Candiolo, Turin, Italy ; Institute for Cancer Research and Treatment, Candiolo, Turin, Italy.
authors.forename: Donatella
authors.initials: D
authors.lastname: Marino
authors.affiliation: Medical Oncology Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Universita Politecnica delle Marche, Ancona, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Faloppi
authors.affiliation: Medical Oncology Unit, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Universita Politecnica delle Marche, Ancona, Italy.
authors.forename: Stefano
authors.initials: S
authors.lastname: Cascinu
authors.affiliation: Department of Oncology, University and General Hospital, Udine, Italy.
authors.forename: Gianpiero
authors.initials: G
authors.lastname: Fasola
authors.affiliation: Medical Oncology Department, University of Cagliari, Cagliari, Italy ; General Hospital, Cagliari, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Scartozzi
keywords: AMG 337; colorectal cancer; gastric cancer; onartuzumab; pembrolizumab; ramucirumab; target therapy